Should we screen for gestational diabetes? “The concept of gestational diabetes was popularised before considerations of evidence based medicine came on the scene”

BMJ

Volumn 315, Issue 7110, 1997, Pages 736-737

  Jarrett, R J ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; HYPERGLYCEMIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SCREENING; SHORT SURVEY;

COST-BENEFIT ANALYSIS; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0030856779     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.315.7110.736     Document Type: Article

References (18)

1. Coustan DR. Management of gestational diabetes mellitus: a self-fulfilling prophecy? JAMA 1996; 275: 1199–1200.
2. Jarrett RJ. Gestational diabetes: a non-entity? BMJ 1993; 306: 37–8.
3. Gabbe SG, Landon MB. Management of diabetes in pregnancy: survey of materno-fetal specialists in the United States. In: Sutherland HW, Stowers JM, Pearson DWM, eds. Carbohydrate metabolism in pregnancy and the newborn IV. London: Springer, 1989: 309–17.
4. Nelson-Piercy C, Gale EAM. Do we know how to screen for gestational diabetes? Current practice in one regional health authority. Diabetic Med 1994; 11: 493–8.
5. O'Sullivan JB, Mahan C. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278–85.
6. Hanson U, Persson B, Thunell S. The relation between Hb Alc in early diabetic pregnancy and the occurrence of spontaneous abortion and malformation in Sweden. Diabetologia 1990; 33: 100–4.
7. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 1995; 18: 1446–51.
8. Molsted-Pedersen L, Damon P, Buschard K. Diabetes diagnosed during pregnancy: follow-up studies. In: Sutherland HW, Stowers JM, Pearson DWM, eds. Carbohydrate metabolism in pregnancy and the newborn IV. London: Springer, 1989: 277–86.
9. Goldenburg RL, Tamura TT. Pre-pregnancy weight and pregnancy outcome. JAMA 1996; 275: 1127–8.
10. Ales KL, Santini DL. Should all pregnant women be screened for gestational glucose intolerance? Lancet 1989; i: 1187–91.
11. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333: 1237–41.
12. Barker DJP. Fetal and infant origins of adult disease. London: BMJ Publishing Group, 1992.
13. Engelgau MM, Aubert RE, Thompson TJ, Herman WH. Screening for NIDDM in nonpregnant adults: a review of principles, screening tests, and recommendations. Diabetes Care 1995; 18: 1606–17.
14. Roberts RN, Moohan JM, Foo RLK, Harley JMG, Traub AI, Hadden DR. Fetal outcome in mothers with IGT in pregnancy. Diabetic Med 1993; 10: 438–43.
15. Samanta A, Burden ML, Burden AC, Jones GR. Glucose tolerance during pregnancy in Asian women. Diabetes Res Clin Prac 1989; 7: 127–35.
16. American College of Obstetricians and Gynecologists. Management of diabetes mellitus in pregnancy. Washington: ACOG, 1994.
17. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams and Wilkins, 1996.
18. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 7: 1183–97.